Relationship between Vitamin K and Glucose Metabolism

doi:10.12114/j.issn.1007-9572.2019.00.551

Abstract

Abstract: Diabetes is a worldwide public health disease that poses a threat to human health.Vitamin K could act on insulin resistance and glucose metabolism via vitamin K-dependent proteins （VKDPS）——osteocalcin （OC），growth arrest-specific 6 protein （Gas-6），and matrix Gla protein （MGP） and adiponectin，inflammatory factors and lipid，which may provide new ideas for the treatment of diabetes.The relationship between vitamin K and glucose metabolism has been tested in many animal experimentations and clinical experiments.

Key words: Vitamin K, Glucose metabolism, Diabetes mellitus, Insulin resistance, Review

摘要： 糖尿病是威胁人类健康的世界性公共卫生问题，维生素K通过介导维生素K依赖蛋白（VKDPS）—骨钙素（OC）、生长抑制因子6（Gas-6）、羧基谷氨酸蛋白（MGP）以及脂联素、炎性因子及脂质变化来影响胰岛素抵抗及糖代谢，这可能给糖尿病治疗提供了新思路。维生素K与糖代谢的关系已在许多动物实验及临床试验中得到证实。

关键词: 维生素K, 糖代谢, 糖尿病, 胰岛素抵抗, 综述

REN Ruijun,TAN Jing. Relationship between Vitamin K and Glucose Metabolism　[J]. Chinese General Practice, 2019, 22(29): 3539-3543. DOI: 10.12114/j.issn.1007-9572.2019.00.551.
任芮君,谭竞. 维生素K与糖代谢研究进展[J]. 中国全科医学, 2019, 22(29): 3539-3543. DOI: 10.12114/j.issn.1007-9572.2019.00.551.

References

［1］WANG L M，GAO P，ZHANG M，et al．Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013［J］．JAMA，2017，317（24）：2515-2523．DOI：10.1001/jama.2017.7596.
［2］ARDISSON KORAT A V，WILLETT W C，HU F B.Diet，lifestyle，and genetic risk factors for type 2 diabetes：a review from the nurses' health study，nurses' health study 2，and health professionals' follow-up study［J］．Curr Nutr Rep，2014，3（4）：345-354．DOI：10.1007/s13668-014-0103-5.
［3］BOOTH S L.Roles for vitamin K beyond coagulation［J］．Annu Rev Nutr，2009，29：89-110．DOI：10.1146/annurev-nutr-080508-141217.
［4］SHEARER M J，FU X Y，BOOTH S L.Vitamin K nutrition，metabolism，and requirements：current concepts and future research［J］．Adv Nutr，2012，3（2）：182-195．DOI：10.3945/an.111.001800.
［5］IWAMOTO J，TAKEDA T，SATO Y.Menatetrenone （vitamin K2） and bone quality in the treatment of postmenopausal osteoporosis［J］．Nutr Rev，2006，64（12）：509-517．DOI：10.1111/j.1753-4887.2006.tb00184.x.
［6］VISSERS L E T，DALMEIJER G W，BOER J M A，et al．The relationship between vitamin K and peripheral arterial disease［J］．Atherosclerosis，2016，252：15-20．DOI：10.1016/j.atherosclerosis.2016.07.915.
［7］MANNA P，KALITA J.Beneficial role of vitamin K supplementation on insulin sensitivity，glucose metabolism，and the reduced risk of type 2 diabetes：a review［J］．Nutrition，2016，32（7/8）：732-739．DOI：10.1016/j.nut.2016.01.011.
［8］VARSHA M K，THIAGARAJAN R，MANIKANDAN R，et al．Vitamin K1 alleviates streptozotocin-induced type 1 diabetes by mitigating free radical stress，as well as inhibiting NF-κB activation and iNOS expression in rat pancreas［J］．Nutrition，2015，31（1）：214-222．DOI：10.1016/j.nut.2014.05.012.
［9］RAZA H，JOHN A.Streptozotocin-induced cytotoxicity，oxidative stress and mitochondrial dysfunction in human hepatoma HepG2 cells［J］．Int J Mol Sci，2012，13（5）：5751-5767．DOI：10.3390/ijms13055751.
［10］HUSSEIN A G，MOHAMED R H，SHALABY S M，et al．Vitamin K2 alleviates type 2 diabetes in rats by induction of osteocalcin gene expression［J］．Nutrition，2018，47：33-38．DOI：10.1016/j.nut.2017.09.016.
［11］DIHINGIA A，OZAH D，GHOSH S，et al．Vitamin K1 inversely correlates with glycemia and insulin resistance in patients with type 2 diabetes （T2D） and positively regulates SIRT1/AMPK pathway of glucose metabolism in liver of T2D mice and hepatocytes cultured in high glucose［J］．J Nutr Biochem，2018，52：103-114．DOI：10.1016/j.jnutbio.2017.09.022.
［12］YOSHIDA M，BOOTH S L，MEIGS J B，et al．Phylloquinone intake，insulin sensitivity，and glycemic status in men and women［J］．Am J Clin Nutr，2008，88（1）：210-215．DOI：10.1093/ajcn/88.1.210.
［13］YOSHIDA M，JACQUES P F，MEIGS J B，et al．Effect of vitamin K supplementation on insulin resistance in older men and women［J］．Diabetes Care，2008，31（11）：2092-2096．DOI：10.2337/dc08-1204.
［14］ASEMI Z，RAYGAN F，BAHMANI F，et al．The effects of vitamin D，K and calcium co-supplementation on carotid intima-media thickness and metabolic status in overweight type 2 diabetic patients with CHD［J］．Br J Nutr，2016，116（2）：286-293．DOI：10.1017/S0007114516001847.
［15］KARAMALI M，ASHRAFI M，RAZAVI M，et al．The effects of calcium，vitamins D and K co-supplementation on markers of insulin metabolism and lipid profiles in vitamin D-deficient women with polycystic ovary syndrome［J］．Exp Clin Endocrinol Diabetes，2017，125（5）：316-321．DOI：10.1055/s-0043-104530.
［16］KNAPEN M H J，JARDON K M，VERMEER C.Vitamin K-induced effects on body fat and weight：results from a 3-year vitamin K2 intervention study［J］．Eur J Clin Nutr，2018，72（1）：136-141．DOI：10.1038/ejcn.2017.146.
［17］CHOI H J，YU J，CHOI H，et al．Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism：a placebo-controlled trial［J］．Diabetes Care，2011，34（9）：e147．DOI：10.2337/dc11-0551.
［18］YOSHIDA M，BOOTH S L，MEIGS J B，et al．Phylloquinone intake，insulin sensitivity，and glycemic status in men and women［J］．Am J Clin Nutr，2008，88（1）：210-215．DOI：10.1093/ajcn/88.1.210.
［19］NEVE A，CORRADO A，CANTATORE F P.Osteocalcin：skeletal and extra-skeletal effects［J］．J Cell Physiol，2013，228（6）：1149-1153．DOI：10.1002/jcp.24278.
［20］IVASKA K K，HENTUNEN T A，V??R?NIEMI J，et al．Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro［J］．J Biol Chem，2004，279（18）：18361-18369．DOI：10.1074/jbc.M314324200.
［21］FERRON M，WEI J W，YOSHIZAWA T，et al．Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism［J］．Cell，2010，142（2）：296-308．DOI：10.1016/j.cell.2010.06.003.
［22］FERRON M，HINOI E，KARSENTY G，et al．Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice［J］．Proc Natl Acad Sci USA，2008，105（13）：5266-5270．DOI：10.1073/pnas.0711119105.
［23］RASEKHI H，KARANDISH M，JALALI M T，et al．The effect of vitamin K1 supplementation on sensitivity and insulin resistance via osteocalcin in prediabetic women：a double-blind randomized controlled clinical trial［J］．Eur J Clin Nutr，2015，69（8）：891-895．DOI：10.1038/ejcn.2015.17.
［24］PITTAS A G，HARRIS S S，ELIADES M，et al．Association between serum osteocalcin and markers of metabolic phenotype［J］．J Clin Endocrinol Metab，2009，94（3）：827-832．DOI：10.1210/jc.2008-1422.
［25］SALEEM U，MOSLEY T H Jr，KULLO I J.Serum osteocalcin is associated with measures of insulin resistance，adipokine levels，and the presence of metabolic syndrome［J］．Arterioscler Thromb Vasc Biol，2010，30（7）：1474-1478．DOI：10.1161/ATVBAHA.110.204859.
［26］GRAVENSTEIN K S，NAPORA J K，SHORT R G，et al．Cross-sectional evidence of a signaling pathway from bone homeostasis to glucose metabolism［J］．J Clin Endocrinol Metab，2011，96（6）：E884-890．DOI：10.1210/jc.2010-2589.
［27］RAZNY U，FEDAK D，KIEC-WILK B，et al．Carboxylated and undercarboxylated osteocalcin in metabolic complications of human obesity and prediabetes［J］．Diabetes Metab Res Rev，2017，33（3）．DOI：10.1002/dmrr.2862.
［28］YE R S，SCHERER P E.Adiponectin，driver or passenger on the road to insulin sensitivity?［J］．Mol Metab，2013，2（3）：133-141．DOI：10.1016/j.molmet.2013.04.001.
［29］RASEKHI H，KARANDISH M，JALALI M T，et al．Phylloquinone supplementation improves glycemic status independent of the effects of adiponectin levels in premonopause women with prediabetes：a double-blind randomized controlled clinical trial［J］．J Diabetes Metab Disord，2015，14（1）：1．DOI：10.1186/s40200-014-0127-9.
［30］SUKSOMBOON N，POOLSUP N，DARLI KO KO H.Effect of vitamin K supplementation on insulin sensitivity：a meta-analysis［J］．Diabetes Metab Syndr Obes，2017，10：169-177．DOI：10.2147/DMSO.S137571.
［31］HOTAMISLIGIL G S.Inflammation，metaflammation and immunometabolic disorders［J］．Nature，2017，542（7640）：177-185．DOI：10.1038/nature21363.
［32］OHSAKI Y，SHIRAKAWA H，MIURA A，et al．Vitamin K suppresses the lipopolysaccharide-induced expression of inflammatory cytokines in cultured macrophage-like cells via the inhibition of the activation of nuclear factor κB through the repression of IKKα/β phosphorylation［J］．J Nutr Biochem，2010，21（11）：1120-1126．DOI：10.1016/j.jnutbio.2009.09.011.
［33］SHEA M K，DALLAL G E，DAWSON-HUGHES B，et al．Vitamin K，circulating cytokines，and bone mineral density in older men and women［J］．Am J Clin Nutr，2008，88（2）：356-363．DOI：10.1093/ajcn/88.2.356.
［34］JUANOLA-FALGARONA M，SALAS-SALVADó J，ESTRUCH R，et al．Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk［J］．Cardiovasc Diabetol，2013，12：7．DOI：10.1186/1475-2840-12-7.
［35］VARSHA M K，THIAGARAJAN R，MANIKANDAN R，et al．
Vitamin K1 alleviates streptozotocin-induced type 1 diabetes by mitigating free radical stress，as well as inhibiting NF-κB activation and iNOS expression in rat pancreas［J］．Nutrition，2015，31（1）：214-222．DOI：10.1016/j.nut.2014.05.012.
［36］HSIEH C H，CHUNG R H，LEE W J，et al．Effect of common genetic variants of growth arrest-specific 6 gene on insulin resistance，obesity and type 2 diabetes in an Asian population［J］．PLoS One，2015，10（8）：e0135681．DOI：10.1371/journal.pone.0135681.
［37］WU K S，HUNG Y J，LEE C H，et al．The involvement of GAS6 signaling in the development of obesity and associated inflammation［J］．Int J Endocrinol，2015，2015：202513．DOI：10.1155/2015/202513.
［38］KUO F C，HUNG Y J，SHIEH Y S，et al．The levels of plasma growth arrest-specific protein 6 is associated with insulin sensitivity and inflammation in women［J］．Diabetes Res Clin Pract，2014，103（2）：304-309．
［39］VOLLENWEIDER P，VON ECKARDSTEIN A，WIDMANN C.HDLs，diabetes，and metabolic syndrome［J］．Handb Exp Pharmacol，2015，224：405-421．
［40］KNAPEN M H J，JARDON K M，VERMEER C.Vitamin K-induced effects on body fat and weight：results from a 3-year vitamin K2 intervention study［J］．Eur J Clin Nutr，2018，72（1）：136-141．
［41］SOGABE N，MARUYAMA R，BABA O，et al．Effects of long-term vitamin K（1）（phylloquinone） or vitamin K（2）（menaquinone-4） supplementation on body composition and serum parameters in rats［J］．Bone，2011，48（5）：1036-1042．DOI：10.1016/j.bone.2011.01.020.
［42］WUYTS J，DHONDT A.The role of vitamin K in vascular calcification of patients with chronic kidney disease［J］．Acta Clin Belg，2016，71（6）：462-467．
［43］ANTONOPOULOS S，MYLONOPOULOU M，ANGELIDI A M，et al．Association of matrix gamma-carboxyglutamic acid protein levels with insulin resistance and Lp（a） in diabetes：a cross-sectional study［J］．Diabetes Res Clin Pract，2017，130：252-257.

[1]	WANG Yang, ZHAO Shiting, CHEN Yingying, SUN Zilin, QIU Shanhu. Key Points of Exercise Intervention and Implementation for People with Complications of Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(21): 2989-2994.
[2]	LI Jiawei, GAO Xinyi, GE Aoqi, LI Juanjuan, YUAN Beibei. Demand and Associated Factors for Integrated Medical Care and Preventive Services among Patients with Type 2 Diabetes [J]. Chinese General Practice, 2026, 29(21): 3028-3039.
[3]	PAN Ziyun, YIN Hao, LIN Zhirou, MAO Jingyi, HUANG Yan, LUO Yanhua, XIAO Jiafu, HU Yin. From Mechanism to Therapy: Diabetic Autonomic Neuropathy [J]. Chinese General Practice, 2026, 29(21): 2982-2988.
[4]	AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003.
[5]	GE Dan, WANG Zhi, DING Qun, GUO Tonglan, XU Tongdao. Relationship between Remnant Cholesterol and Non-alcoholic Fatty Liver Disease as well as Progressive Liver Fibrosis in Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(20): 2854-2859.
[6]	ZHANG Xiaojuan, LIU Yang, PENG Bo, YE Yuan, ZHU Kun. Study on the Prevention and Treatment of Hypertension and Diabetes Mellitus in Community Hospital [J]. Chinese General Practice, 2026, 29(19): 2614-2620.
[7]	JIAN Yingchun, ZENG Yongqin, ZHANG Haiping, WANG Zhengdi, AN Ke, YAN Rui. Recent Advances in Mitochondrial Dysfunction in Chronic Metabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2577-2584.
[8]	LI Yachan, YANG Yang, XU Qianting, KE Tingyu. Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(18): 2482-2488.
[9]	LI Menglin, DING Fang, QIAN Yu, PU Dong, DU Qianqian, GUAN Tianhang, HE Yilin. Study on Glycemic Control Status and Influencing Factors among Community Diabetic Patients [J]. Chinese General Practice, 2026, 29(17): 2334-2339.
[10]	WANG Rui, LUO Dan, YANG Cuicui, WENG Xinyi, WANG Yubing, XU Jingjing. Complex Network Analysis of Resilience in Adolescents with Type 1 Diabetes Mellitus Based on Multi-sourced Stigma [J]. Chinese General Practice, 2026, 29(16): 2264-2272.
[11]	FU Mingyuan, YU Xiaoyi, GE Caiying, KONG Min. Impaired Awareness of Hypoglycemia: Prevalence and Determinants among Community-based Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(16): 2252-2258.
[12]	JIN Chunhua, ZHANG Yawen, LI Lianxi. Association between Serum Bilirubin Within the Normal Range and Carotid Plaques in Elderly Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(15): 1986-1991.
[13]	YU Jie, WU Chunxiang, CAI Ning, ZHU Xiaoxia, SHEN Li. Study on Multidimensional Healthcare-seeking Behavior Patterns and Influencing Factors in Diabetic Patients [J]. Chinese General Practice, 2026, 29(14): 1827-1839.
[14]	YAN Beibei, XU Huaifu. Children's Type 1 Diabetes-specific Self-reported Outcomes Scales: Measurement Properties Evaluation Based on COSMIN Guidelines [J]. Chinese General Practice, 2026, 29(12): 1624-1632.
[15]	YANG Rong, JIN Hua, SHI Ling, YI Chuntao, HOU Jin, CHEN Chen, HUAN Hongmei, NI Hengru, YU Dehua. A Survey on the Quality of Diabetes Normative Management at Grassroots Level [J]. Chinese General Practice, 2026, 29(12): 1541-1547.